Stability evaluation of Tc-99m radiolabeled GRPr antagonist with amino acid chelators-Reference-Cited by-同舟云学术

Stability evaluation of Tc-99m radiolabeled GRPr antagonist with amino acid chelators

Published:2018-12-06 Issue:1 Volume:319 Page:453-458
ISSN:0236-5731
Container-title:Journal of Radioanalytical and Nuclear Chemistry
language:en
Short-container-title:J Radioanal Nucl Chem

Author:

Zhong Zhengkun,Kan Wentao,Liao Wei

Funder

Science and Technology Development of Foundation of China Academy of Engineering Physics

China National Natural Science Foundation

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Spectroscopy,Pollution,Radiology, Nuclear Medicine and imaging,Nuclear Energy and Engineering,Analytical Chemistry

Link

http://link.springer.com/article/10.1007/s10967-018-6363-6/fulltext.html

Reference18 articles.

1. Schroeder RPJ (2009) Peptide receptor imaging of prostate cancer with radiolabeled bombesin analogues. Methods 48:200–204

2. Mansi R (2013) Targeting GRPR in urological cancers-from basic research to clinical application. Nat Rev Urol 10:235–244

3. Carsten K (2013) Hybrid bombesin analogues: combining an agonist and an antagonist in defined distances for optimized tumor targeting. J Am Chem Soc 135:16793–16796

4. Mansi R (2011) Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides. Clin Cancer Res 15:5240–5249

5. Ginj M (2006) Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. Proc Natl Acad Sci USA 103:16436–16441